By Greg Mannix, Vice President International Business Development, General Manager Europe, LSN
Biocat will host a lunch keynote session at RESI Europe 2024 on June 17 at the Hotel Hilton Diagonal Mar in Barcelona. The session, titled “Catalonia’s Advanced Therapies Ecosystem: Shaping the Future of ATMPs in Europe,” will take place in the Ballroom, starting at 12 PM. Leading experts will discuss the pivotal role of Catalonia’s advanced therapies ecosystem in driving innovation and clinical advancements in Advanced Therapy Medicinal Products (ATMPs) across Europe. This session, organized by Biocat, will delve into the region’s innovative landscape, highlighting groundbreaking research, investment opportunities, and cutting-edge developments.
The esteemed panel will be moderated by Robert Fabregat, CEO of BIOCAT, and features prominent figures in the field:
- Fina Lladós, Vice President General Manager Iberia at Amgen
- Silvia Martín-Lluesma, Clinical Senior Manager of Advanced Therapies at Vall d’Hebron Institute of Oncology (VHIO)
- Antoni Matilla, Cofounder and Director of Biointaxis
- Lluís Pareras, Founder and Managing Partner at Invivo Ventures
- Esteve Trias, Executive Medical Director at Leitat Technological Center
Attendees will gain invaluable insights into how Catalonia’s collaborative efforts and strategic initiatives propel Europe to the forefront of advanced therapies. This session is a must-attend for investors, researchers, and industry professionals committed to advancing the field of ATMPs and shaping the future of healthcare. Don’t miss this opportunity to engage with key players and learn about the future of advanced therapies in Europe! If you haven’t registered for RESI Europe yet, you can register now to secure your spot.
Next Phase Newsletter 
Leave a comment